Log in to your Inderes Free account to see all free content on this page.
Glycorex Transplantation
3.18
SEK
-10.92 %
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-10.92%
+55.88%
+73.77%
+98.75%
+284.06%
+127.14%
-64.07%
-70.56%
-68.68%
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Read moreMarket cap
234.86M SEK
Turnover
335.74K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
27.2.
2025
Annual report '24
23.5.
2025
Interim report Q1'25
27.5.
2025
General meeting '25
ShowingAll content types
Glycorex Transplantation AB (GTAB B): Results from Norwegian platelet evaluation presented at conference
Glycorex Transplantation AB: First ABO-incompatible transplantation in Argentina with Glycosorb® ABO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio